- Home
- Publications
- Publication Search
- Publication Details
Title
Amyloid Imaging: Poised for Integration into Medical Practice
Authors
Keywords
Alzheimer’s disease, amyloid, imaging, therapeutics, PET-CT
Journal
Neurotherapeutics
Volume 14, Issue 1, Pages 54-61
Publisher
Springer Nature
Online
2016-08-29
DOI
10.1007/s13311-016-0474-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early [18F]florbetaben and [11C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer’s disease
- (2016) Solveig Tiepolt et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study
- (2016) J. Seibyl et al. JOURNAL OF NUCLEAR MEDICINE
- [ 18 F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-β pathology
- (2015) Dietmar Rudolf Thal et al. Alzheimers & Dementia
- Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
- (2015) Osama Sabri et al. Alzheimers & Dementia
- Use of Standardized Uptake Value Ratios Decreases Interreader Variability of [18F] Florbetapir PET Brain Scan Interpretation
- (2015) A. P. Nayate et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Amyloid PET imaging in multiple sclerosis: an 18F-florbetaben study
- (2015) Jordi A. Matías-Guiu et al. BMC Neurology
- Amyloid imaging in cognitively normal older adults: comparison between 18F-flutemetamol and 11C-Pittsburgh compound B
- (2015) Katarzyna Adamczuk et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A Semiautomated Method for Quantification of F 18 Florbetapir PET Images
- (2015) A. D. Joshi et al. JOURNAL OF NUCLEAR MEDICINE
- Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben -Amyloid PET Scans
- (2015) M. Rullmann et al. JOURNAL OF NUCLEAR MEDICINE
- Age dependence of brain -amyloid deposition in Down syndrome: An [18F]florbetaben PET study
- (2015) D. Jennings et al. NEUROLOGY
- Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density
- (2015) Craig Curtis et al. JAMA Neurology
- Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence Imaging
- (2015) Masafumi Shimojo et al. Frontiers in Neuroscience
- Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer’s disease
- (2015) Guruswami SM Sundaram et al. EJNMMI Research
- FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice
- (2015) Behrooz H Yousefi et al. EJNMMI Research
- VALUE OF AMYLOID IMAGING FOR PREDICTING CONVERSION TO DEMENTIA IN MCI SUBJECTS WITH INITIALLY INDETERMINATE FDG-PET SCANS
- (2014) Daniel Silverman et al. Alzheimers & Dementia
- Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study
- (2014) Kevin T Ong et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Automated Quantification of 18F-Flutemetamol PET Activity for Categorizing Scans as Negative or Positive for Brain Amyloid: Concordance with Visual Image Reads
- (2014) L. Thurfjell et al. JOURNAL OF NUCLEAR MEDICINE
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Predictive Accuracy of Amyloid Imaging for Progression From Mild Cognitive Impairment to Alzheimer Disease With Different Lengths of Follow-up
- (2014) Yan Ma et al. MEDICINE
- Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study
- (2014) P M Doraiswamy et al. MOLECULAR PSYCHIATRY
- A review of β-amyloid neuroimaging in Alzheimer's disease
- (2014) Paul A. Adlard et al. Frontiers in Neuroscience
- [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer’s disease
- (2013) Shizuo Hatashita et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Neuropathologic Heterogeneity Does Not Impair Florbetapir-Positron Emission Tomography Postmortem Correlates
- (2013) Brittany N. Dugger et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Update on Appropriate Use Criteria for Amyloid PET Imaging: Dementia Experts, Mild Cognitive Impairment, and Education
- (2013) K. A. Johnson et al. JOURNAL OF NUCLEAR MEDICINE
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Pittsburgh compound B and the postmortem diagnosis of alzheimer disease
- (2012) Dana M. Niedowicz et al. ANNALS OF NEUROLOGY
- Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography
- (2012) David A Wolk et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Amyloid- Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods
- (2012) S. M. Landau et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical Validation of 18F-AZD4694, an Amyloid- -Specific PET Radioligand
- (2012) Z. Cselenyi et al. JOURNAL OF NUCLEAR MEDICINE
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
- (2012) Christopher M Clark et al. LANCET NEUROLOGY
- In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer
- (2012) Michelle T. Fodero-Tavoletti et al. NUCLEAR MEDICINE AND BIOLOGY
- Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls
- (2011) Henryk Barthel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias
- (2011) V. L. Villemagne et al. JOURNAL OF NUCLEAR MEDICINE
- Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
- (2011) Henryk Barthel et al. LANCET NEUROLOGY
- 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial
- (2010) Rik Vandenberghe et al. ANNALS OF NEUROLOGY
- Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand
- (2010) Anders Juréus et al. JOURNAL OF NEUROCHEMISTRY
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologies
- (2009) Paul W. Thompson et al. JOURNAL OF NEUROCHEMISTRY
- Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease
- (2009) N. Nelissen et al. JOURNAL OF NUCLEAR MEDICINE
- The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation
- (2008) William E Klunk et al. CURRENT OPINION IN NEUROLOGY
- Clinical severity of Alzheimer's disease is associated with PIB uptake in PET
- (2008) Timo Grimmer et al. NEUROBIOLOGY OF AGING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now